Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin Lymphoma.

Overview of attention for article published in Cancer Discovery, May 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 77 X posts from 35 X users, with an upper bound of 161,969 followers.

RT @TaliLev123: 🌟Highlighting for #AACRtii23 : Sequential single-cell transcriptional and protein marker profiling reveals TIGIT as a marke…

RT @TaliLev123: 🌟Highlighting for #AACRtii23 : Sequential single-cell transcriptional and protein marker profiling reveals TIGIT as a marke…

RT @TaliLev123: 🌟Highlighting for #AACRtii23 : Sequential single-cell transcriptional and protein marker profiling reveals TIGIT as a marke…

RT @TaliLev123: 🌟Highlighting for #AACRtii23 : Sequential single-cell transcriptional and protein marker profiling reveals TIGIT as a marke…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 73 additional X posts.